GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Hypertension Diagnostics Inc (OTCPK:HDII) » Definitions » Cyclically Adjusted Revenue per Share

Hypertension Diagnostics (Hypertension Diagnostics) Cyclically Adjusted Revenue per Share : $0.00 (As of Sep. 2019)


View and export this data going back to 1998. Start your Free Trial

What is Hypertension Diagnostics Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Hypertension Diagnostics's adjusted revenue per share for the three months ended in Sep. 2019 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-14), Hypertension Diagnostics's current stock price is $0.0001. Hypertension Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2019 was $0.00. Hypertension Diagnostics's Cyclically Adjusted PS Ratio of today is .


Hypertension Diagnostics Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Hypertension Diagnostics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypertension Diagnostics Cyclically Adjusted Revenue per Share Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hypertension Diagnostics's Cyclically Adjusted Revenue per Share

For the Shell Companies subindustry, Hypertension Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypertension Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Cyclically Adjusted PS Ratio falls into.



Hypertension Diagnostics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hypertension Diagnostics's adjusted Revenue per Share data for the three months ended in Sep. 2019 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=0/107.6113*107.6113
=0.000

Current CPI (Sep. 2019) = 107.6113.

Hypertension Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200412 0.011 83.276 0.014
200503 0.008 83.987 0.010
200506 0.013 84.461 0.017
200509 0.012 85.647 0.015
200512 0.016 85.015 0.020
200603 0.016 85.805 0.020
200606 0.007 86.516 0.009
200609 0.011 86.279 0.014
200612 0.014 86.437 0.017
200703 0.012 87.780 0.015
200706 0.011 88.412 0.013
200709 0.004 88.412 0.005
200712 0.004 88.491 0.005
200803 0.003 88.965 0.004
200806 0.004 91.177 0.005
200809 0.003 91.414 0.004
200812 0.003 89.518 0.004
200903 0.002 90.071 0.002
200906 0.004 90.940 0.005
200909 0.007 90.624 0.008
200912 0.011 90.703 0.013
201003 0.003 91.335 0.004
201006 0.012 91.809 0.014
201009 0.000 92.362 0.000
201012 0.000 92.836 0.000
201103 0.000 94.338 0.000
201106 0.000 94.654 0.000
201109 0.000 95.286 0.000
201112 0.024 94.970 0.027
201203 0.033 96.155 0.037
201206 0.002 96.076 0.002
201209 0.001 96.392 0.001
201212 0.000 95.760 0.000
201303 0.000 97.103 0.000
201612 0.000 101.449 0.000
201712 0.000 103.345 0.000
201812 0.000 105.399 0.000
201903 0.000 106.979 0.000
201906 0.000 107.690 0.000
201909 0.000 107.611 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Hypertension Diagnostics  (OTCPK:HDII) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Hypertension Diagnostics Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypertension Diagnostics (Hypertension Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.